Results 111 to 120 of about 7,695 (151)

High Seroreactivities to Orthoebolaviruses in Rural Cameroon: A Case-Control Study on Nonhuman Primate Bites and a Cross-sectional Survey in Rural Populations. [PDF]

J Infect Dis
Ramassamy JL, Ayouba A, Thaurignac G, Bilounga Ndongo C, Nnuka P, Betsem E, Njouom R, Mpoudi Ngole E, Vanhomwegen J, Hoinard D, England P, Journeaux A, Picard C, Thomas D, Pannetier D, Baize S, Delaporte E, Peeters M, Gessain A.   +18 more
europepmc   +1 more source

Behavioral risk assessment of exposure to wild and domestic animals in response to a Marburg virus disease outbreak, Ghana 2022. [PDF]

One Health
Suu-Ire R, Ball S, Ziekah MY, DeMarco J, Kain M, Agyei AS, Epstein JH.   +6 more
europepmc   +1 more source

Priorities for rapid and cost-effective vaccines to improve outbreak responses. [PDF]

PLoS Biol
Gilbert SC.
europepmc   +1 more source

Unveiling the hidden threats: a review of pathogen diversity and public health risks from bats, rodents, and non-human primates in Zambia (1990-2022). [PDF]

Front Public Health
Munjita SM, Mubemba B, Changula K, Tembo J, Hamoonga R, Bates M, Chitanga S, Munsaka S, Simulundu E.   +8 more
europepmc   +1 more source

Leveraging an epidemic to establish vaccine clinical trial capacity in a low resource setting: the Ugandan experience. [PDF]

Trials
Muttamba W, Toure A, Wayengera M, Bosa HK, Sabiiti W, Byakika-Kibwika P, Kirenga B.   +6 more
europepmc   +1 more source

Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea. [PDF]

Nat Commun
Akoi Boré J, Timothy JWS, Tipton T, Kekoura I, Hall Y, Hood G, Longet S, Fornace K, Lucien MS, Fehling SK, Koivogui BK, Coggins SA, Laing ED, Broder CC, Magassouba NF, Strecker T, Rossman J, Konde K, Carroll MW.   +18 more
europepmc   +1 more source

Marburg Virus Disease in Rwanda - Centering Both Evidence and Equity. [PDF]

N Engl J Med
Nutt CT.
europepmc   +1 more source

Infection prevention and control studies for care of patients with suspected or confirmed filovirus disease in healthcare settings, with focus on Ebola and Marburg: an integrative review. [PDF]

BMJ Public Health
Frankfurter RG, Willet V, Richardson ET, Rutherford GW, Baller A, Kelly JD.   +5 more
europepmc   +1 more source

Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats. [PDF]

Vaccines (Basel)
Parish LA, Rele S, Hofmeyer KA, Luck BB, Wolfe DN.   +4 more
europepmc   +1 more source